Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. (2022)

First Author: ACTIV-3/TICO Study Group
Attributed to:  Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/m22-1503

PubMed Identifier: 35939810

Publication URI: http://europepmc.org/abstract/MED/35939810

Type: Journal Article/Review

Volume: 175

Parent Publication: Annals of internal medicine

Issue: 9

ISSN: 0003-4819